NeuroSense Therapeutics receives Nasdaq notices over listing requirements
at seekingalpha.com (Fri, 3-Apr 10:54 AM)
NeuroSense Therapeutics Faces Nasdaq Deficiency Notices but Retains Listing Status
at www.tipranks.com (Fri, 3-Apr 9:47 AM)
Neurosense Therapeutics Ltd. (NRSN) Receives a Buy from Roth MKM
at www.tipranks.com (Thu, 2-Apr 8:46 AM)
Noble Financial Remains a Buy on Neurosense Therapeutics Ltd. (NRSN)
at www.tipranks.com (Wed, 1-Apr 9:56 AM)
NeuroSense Therapeutics Posts 2025 Results as PrimeC Advances Toward Phase 3 ALS Trial
at www.tipranks.com (Tue, 31-Mar 5:22 PM)
NeuroSense Therapeutics reports FY results, GAAP EPS of $0.44
at seekingalpha.com (Tue, 31-Mar 11:18 AM)
